A personalized vaccine is showing promise in the treatment of aggressive brain cancer, with some studies suggesting it may boost survival and immune response. The vaccine, which may involve dna or mrna technology, has shown potential in treating glioblastoma, a type of brain cancer. Research in this area is ongoing, with various approaches being explored, including noninvasive methods and treatments that target cancer recurrence.